IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention?
作者信息
Johnston Sebastian L
机构信息
National Heart and Lung InstituteImperial College LondonLondon, United Kingdomand.
Asthma UK Centre in Allergic Mechanisms of AsthmaLondon, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2020 Jan 1;201(1):9-11. doi: 10.1164/rccm.201909-1850ED.
Abstract
摘要
相似文献
1
IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention?气道疾病中的干扰素治疗：预防性治疗是预防病情加重的新方法吗？
Am J Respir Crit Care Med. 2020 Jan 1;201(1):9-11. doi: 10.1164/rccm.201909-1850ED.
2
Relevance of the selected cytokine release (TNF-alpha, IL-6, IFN-gamma, and IFN-alpha) to the exacerbation of bronchial asthma from airway mycotic infections. Predominant role of TFN-alpha?所选细胞因子释放（肿瘤坏死因子-α、白细胞介素-6、干扰素-γ和干扰素-α）与气道真菌感染导致支气管哮喘加重的相关性。肿瘤坏死因子-α的主要作用？
J Investig Allergol Clin Immunol. 2002;12(3):182-91.
3
Identification of IFN-γ and IL-27 as Critical Regulators of Respiratory Syncytial Virus-Induced Exacerbation of Allergic Airways Disease in a Mouse Model.在小鼠模型中鉴定IFN-γ和IL-27为呼吸道合胞病毒诱导的过敏性气道疾病加重的关键调节因子。
J Immunol. 2018 Jan 1;200(1):237-247. doi: 10.4049/jimmunol.1601950. Epub 2017 Nov 22.
4
A Microengineered Airway Lung Chip Models Key Features of Viral-induced Exacerbation of Asthma.微工程气道肺芯片模型模拟病毒诱发哮喘加重的关键特征。
Am J Respir Cell Mol Biol. 2020 Nov;63(5):591-600. doi: 10.1165/rcmb.2020-0010MA.
5
Inflammatory and antiviral responses to influenza A virus infection are dysregulated in pregnant mice with allergic airway disease.在患有过敏性气道疾病的妊娠小鼠中，流感病毒感染的炎症和抗病毒反应被失调。
Am J Physiol Lung Cell Mol Physiol. 2023 Sep 1;325(3):L385-L398. doi: 10.1152/ajplung.00232.2022. Epub 2023 Jul 18.
6
United airway disease.联合气道疾病。
Acta Biomed. 2021 Nov 29;92(S7):e2021526. doi: 10.23750/abm.v92iS7.12399.
7
Treatment with -derived VacA attenuates allergic airway disease.用 -derived VacA 治疗可减轻过敏性气道疾病。
Front Immunol. 2023 Jan 24;14:1092801. doi: 10.3389/fimmu.2023.1092801. eCollection 2023.
8
Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases.哮喘及其他小儿呼吸道疾病中的气道一氧化氮测量
J Pediatr. 2000 Jul;137(1):14-20. doi: 10.1067/mpd.2000.107526.
9
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南（2024年版）]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
10
Viral infection in asthma.哮喘中的病毒感染
Allergol Int. 2008 Mar;57(1):21-31. doi: 10.2332/allergolint.R-07-156. Epub 2008 Mar 1.
引用本文的文献
1
Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferrets.干扰素作为一种免疫佐剂，可增强雪貂感染乙型流感病毒及接种疫苗后的抗体反应。
NPJ Vaccines. 2024 Oct 24;9(1):199. doi: 10.1038/s41541-024-00973-2.
2
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial.变应原免疫治疗增强过敏性哮喘患者气道上皮的抗病毒免疫（VITAL 研究）：一项双盲随机对照试验。
Am J Respir Crit Care Med. 2023 May 1;207(9):1161-1170. doi: 10.1164/rccm.202209-1708OC.
3
Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease.基于血液的慢性阻塞性肺疾病转录风险评分的建立。
Am J Respir Crit Care Med. 2022 Jan 15;205(2):161-170. doi: 10.1164/rccm.202107-1584OC.
4
COPD Is Associated with Elevated IFN-β Production by Bronchial Epithelial Cells Infected with RSV or hMPV.COPD 与 RSV 或 hMPV 感染的支气管上皮细胞中 IFN-β 的产生增加有关。
Viruses. 2021 May 14;13(5):911. doi: 10.3390/v13050911.
5
M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbations.M1 样巨噬细胞是抗病毒干扰素的强效产生者，而在鼻病毒引起的哮喘加重期间，M1 相关标志物阳性的肺巨噬细胞减少。
EBioMedicine. 2020 Apr;54:102734. doi: 10.1016/j.ebiom.2020.102734. Epub 2020 Apr 9.
本文引用的文献
1
Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.呼吸道病毒感染期间 IFN-β 反应的动力学。治疗策略的见解。
Am J Respir Crit Care Med. 2020 Jan 1;201(1):83-94. doi: 10.1164/rccm.201901-0214OC.
2
Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.转录组网络鉴定儿童病毒和非病毒哮喘恶化的机制。
Nat Immunol. 2019 May;20(5):637-651. doi: 10.1038/s41590-019-0347-8. Epub 2019 Apr 8.
3
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.气道葡萄糖在慢性阻塞性肺疾病患者细菌感染中的作用。
J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. doi: 10.1016/j.jaci.2017.10.017. Epub 2018 Jan 5.
4
Colds as predictors of the onset and severity of COPD exacerbations.感冒作为慢性阻塞性肺疾病急性加重发作和严重程度的预测指标。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 10;12:839-848. doi: 10.2147/COPD.S127146. eCollection 2017.
5
Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile.Toll样受体7在重症哮喘中表达降低，并与微小RNA谱改变有关。
Am J Respir Crit Care Med. 2016 Jul 1;194(1):26-37. doi: 10.1164/rccm.201502-0280OC.
6
Impaired Antiviral Stress Granule and IFN-β Enhanceosome Formation Enhances Susceptibility to Influenza Infection in Chronic Obstructive Pulmonary Disease Epithelium.抗病毒应激颗粒和干扰素-β增强体形成受损会增加慢性阻塞性肺疾病上皮细胞对流感感染的易感性。
Am J Respir Cell Mol Biol. 2016 Jul;55(1):117-27. doi: 10.1165/rcmb.2015-0306OC.
7
Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.慢性阻塞性肺疾病急性加重期的氧化应激、亚硝化应激与组蛋白去乙酰化酶-2活性
Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.
8
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.吸入式干扰素-β对病毒感染所致哮喘症状恶化的影响。一项随机试验。
Am J Respir Crit Care Med. 2014 Jul 15;190(2):145-54. doi: 10.1164/rccm.201312-2235OC.
9
EAACI position statement on asthma exacerbations and severe asthma.欧洲变应性反应和临床免疫学会关于哮喘加重和重症哮喘的立场声明
Allergy. 2013 Dec;68(12):1520-31. doi: 10.1111/all.12275. Epub 2013 Nov 6.
10
Rhinovirus-induced interferon production is not deficient in well controlled asthma.鼻病毒诱导的干扰素产生在良好控制的哮喘中并不缺乏。
Thorax. 2014 Mar;69(3):240-6. doi: 10.1136/thoraxjnl-2012-202909. Epub 2013 Oct 14.
Zotero 插件